Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):173-183. doi: 10.1007/s00259-015-3149-8. Epub 2015 Aug 22.

Abstract

Purpose: The PET radioligand [(11)C]PBR28 binds to the translocator protein (TSPO), a marker of brain immune activation. We examined the reproducibility of [(11)C]PBR28 binding in healthy subjects with quantification on a regional and voxel-by-voxel basis. In addition, we performed a preliminary analysis of diurnal changes in TSPO availability.

Methods: Twelve subjects were examined using a high-resolution research tomograph and [(11)C]PBR28, six in the morning and afternoon of the same day, and six in the morning on two separate days. Regional volumes of distribution (V T) were derived using a region-of-interest based two-tissue compartmental analysis (2TCM), as well as a parametric approach. Metabolite-corrected arterial plasma was used as input function.

Results: For the whole sample, the mean absolute variability in V T in the grey matter (GM) was 18.3 ± 12.7 %. Intraclass correlation coefficients in GM regions ranged from 0.90 to 0.94. Reducing the time of analysis from 91 to 63 min yielded a variability of 16.9 ± 14.9 %. There was a strong correlation between the parametric and 2TCM-derived GM values (r = 0.99). A significant increase in GM V T was observed between the morning and afternoon examinations when using secondary methods of quantification (p = 0.028). In the subjects examined at the same time of the day, the absolute variability was 15.9 ± 12.2 % for the 91-min 2TCM data.

Conclusion: V T of [(11)C]PBR28 binding showed medium reproducibility and high reliability in GM regions. Our findings support the use of parametric approaches for determining [(11)C]PBR28 V T values, and indicate that the acquisition time could be shortened. Diurnal changes in TSPO binding in the brain may be a potential confounder in clinical studies and should be investigated further.

Keywords: 11C; Brain imaging; PBR28; PET; Test–retest.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbon Radioisotopes*
  • Female
  • Genotype
  • Healthy Volunteers
  • Humans
  • Male
  • Protein Binding
  • Pyrimidines / metabolism*
  • Receptors, GABA / genetics
  • Receptors, GABA / metabolism*
  • Reproducibility of Results
  • Young Adult

Substances

  • (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine
  • Carbon Radioisotopes
  • Pyrimidines
  • Receptors, GABA
  • TSPO protein, human